181 related articles for article (PubMed ID: 23166632)
1. Effect of pullulan nanoparticle surface charges on HSA complexation and drug release behavior of HSA-bound nanoparticles.
Tao X; Zhang Q; Ling K; Chen Y; Yang W; Gao F; Shi G
PLoS One; 2012; 7(11):e49304. PubMed ID: 23166632
[TBL] [Abstract][Full Text] [Related]
2. Effects of Particle Hydrophobicity, Surface Charge, Media pH Value and Complexation with Human Serum Albumin on Drug Release Behavior of Mitoxantrone-Loaded Pullulan Nanoparticles.
Tao X; Jin S; Wu D; Ling K; Yuan L; Lin P; Xie Y; Yang X
Nanomaterials (Basel); 2015 Dec; 6(1):. PubMed ID: 28344259
[TBL] [Abstract][Full Text] [Related]
3. Pullulan-Based Nanoparticle-HSA Complex Formation and Drug Release Influenced by Surface Charge.
Yuan L; Cao Y; Luo Q; Yang W; Wu X; Yang X; Wu D; Tan S; Qin G; Zhou J; Zeng Y; Chen X; Tao X; Zhang Q
Nanoscale Res Lett; 2018 Oct; 13(1):317. PubMed ID: 30306404
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol-Modified Amino-Pullulan Nanoparticles as a Drug Carrier: Comparative Study of Cholesterol-Modified Carboxyethyl Pullulan and Pullulan Nanoparticles.
Tao X; Xie Y; Zhang Q; Qiu X; Yuan L; Wen Y; Li M; Yang X; Tao T; Xie M; Lv Y; Wang Q; Feng X
Nanomaterials (Basel); 2016 Sep; 6(9):. PubMed ID: 28335293
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of biotin modified cholesteryl pullulan as a novel anticancer drug carrier.
Yang W; Wang M; Ma L; Li H; Huang L
Carbohydr Polym; 2014 Jan; 99():720-7. PubMed ID: 24274563
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.
Li Q; Liu C; Zhao X; Zu Y; Wang Y; Zhang B; Zhao D; Zhao Q; Su L; Gao Y; Sun B
Int J Nanomedicine; 2011; 6():397-405. PubMed ID: 21499429
[TBL] [Abstract][Full Text] [Related]
7. Pullulan-based nanoparticles as carriers for transmucosal protein delivery.
Dionísio M; Cordeiro C; Remuñán-López C; Seijo B; Rosa da Costa AM; Grenha A
Eur J Pharm Sci; 2013 Sep; 50(1):102-13. PubMed ID: 23624352
[TBL] [Abstract][Full Text] [Related]
8. Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina.
Kim H; Robinson SB; Csaky KG
Pharm Res; 2009 Feb; 26(2):329-37. PubMed ID: 18958405
[TBL] [Abstract][Full Text] [Related]
9. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
Ulbrich K; Michaelis M; Rothweiler F; Knobloch T; Sithisarn P; Cinatl J; Kreuter J
Int J Pharm; 2011 Mar; 406(1-2):128-34. PubMed ID: 21185364
[TBL] [Abstract][Full Text] [Related]
10. A pH-sensitive nano drug delivery system derived from pullulan/doxorubicin conjugate.
Lu D; Wen X; Liang J; Gu Z; Zhang X; Fan Y
J Biomed Mater Res B Appl Biomater; 2009 Apr; 89(1):177-83. PubMed ID: 18777581
[TBL] [Abstract][Full Text] [Related]
11. Green synthesis of biogenic silver nanoparticles using Solanum tuberosum extract and their interaction with human serum albumin: Evidence of "corona" formation through a multi-spectroscopic and molecular docking analysis.
Ali MS; Altaf M; Al-Lohedan HA
J Photochem Photobiol B; 2017 Aug; 173():108-119. PubMed ID: 28570906
[TBL] [Abstract][Full Text] [Related]
12. Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles.
Esfandyari-Manesh M; Mostafavi SH; Majidi RF; Koopaei MN; Ravari NS; Amini M; Darvishi B; Ostad SN; Atyabi F; Dinarvand R
Daru; 2015 Apr; 23(1):28. PubMed ID: 25903677
[TBL] [Abstract][Full Text] [Related]
13. Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin.
Samkange T; D'Souza S; Obikeze K; Dube A
J Pharm Pharmacol; 2019 Oct; 71(10):1497-1507. PubMed ID: 31385295
[TBL] [Abstract][Full Text] [Related]
14. Rational design of polysorbate 80 stabilized human serum albumin nanoparticles tailored for high drug loading and entrapment of irinotecan.
Taneja N; Singh KK
Int J Pharm; 2018 Jan; 536(1):82-94. PubMed ID: 29146538
[TBL] [Abstract][Full Text] [Related]
15. Titanium dioxide nanoparticles preferentially bind in subdomains IB, IIA of HSA and minor groove of DNA.
Ali K; Abul Qais F; Dwivedi S; Abdel-Salam EM; Ansari SM; Saquib Q; Faisal M; Al-Khedhairy AA; Al-Shaeri M; Musarrat J
J Biomol Struct Dyn; 2018 Aug; 36(10):2530-2542. PubMed ID: 28753123
[TBL] [Abstract][Full Text] [Related]
16. Glycyrrhetinic acid-cyclodextrin grafted pullulan nanoparticles loaded doxorubicin as a liver targeted delivery carrier.
Yang W; Zhang Y; Wang J; Li H; Yang H
Int J Biol Macromol; 2022 Sep; 216():789-798. PubMed ID: 35914549
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Multispectroscopic Analysis on the Interaction and Corona Formation of Human Serum Albumin with Gold/Silver Alloy Nanoparticles.
Selva Sharma A; Ilanchelian M
J Phys Chem B; 2015 Jul; 119(30):9461-76. PubMed ID: 26106942
[TBL] [Abstract][Full Text] [Related]
18. Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery.
Zhang HZ; Li XM; Gao FP; Liu LR; Zhou ZM; Zhang QQ
Drug Deliv; 2010 Jan; 17(1):48-57. PubMed ID: 22747075
[TBL] [Abstract][Full Text] [Related]
19. Novel Delivery of Mitoxantrone with Hydrophobically Modified Pullulan Nanoparticles to Inhibit Bladder Cancer Cell and the Effect of Nano-drug Size on Inhibition Efficiency.
Tao X; Tao T; Wen Y; Yi J; He L; Huang Z; Nie Y; Yao X; Wang Y; He C; Yang X
Nanoscale Res Lett; 2018 Oct; 13(1):345. PubMed ID: 30377872
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types.
Bae S; Ma K; Kim TH; Lee ES; Oh KT; Park ES; Lee KC; Youn YS
Biomaterials; 2012 Feb; 33(5):1536-46. PubMed ID: 22118776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
